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Introduction
Psychiatric disorders are common among patients with 
chronic kidney disease (CKD) and these include depression, 
dementia, delirium, psychosis, anxiety, personality disorders, 
and substance abuse.[1] Depression is the most common 
psychiatric problem in patients with end-stage renal disease 
ESRD.[1-3] The prevalence of depression in CKD patients has 
varied widely in different studies, in different populations, 
using different assessment tools.[1-3] Prevalence rates as high 
as 30% have been reported in some studies.[2-4]
Depression is characterized by both cognitive and somatic 
features. The somatic characteristics of depression are very 
similar to the symptoms of uraemia, such as anorexia, sleep 
disturbances, fatigue, gastrointestinal disorders.[1-3] These 
similarities make the recognition of a depressive disorder 
difficult. Symptoms suggestive of depression include: 
depressed mood most of the time, loss of interest or pleasure 
in most activities for most of the time.[1] 
Some studies have demonstrated a clear relationship 
between depression and mortality in patients treated with 
haemodialysis.[5-10] Depression among peritoneal dialysis 
patients has been associated with higher incidence of 
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peritonitis.[11] It has also been associated with increased 
rate of hospitalization.[12] Co-morbid depression impacts 
negatively on quality of life in CKD[13,14] and improved 
detection and intervention (pharmacological and non-
pharmacological) will improve outcomes. In this study 
we evaluated the frequency of symptoms of depression in 
Nigerians with CKD and also determined the relationship 
between treatment category (pre-dialysis and haemodialysis) 
and frequency of depressive symptoms.
Materials and Methods
This was a cross-sectional study of patients with CKD 
attending the renal out-patients clinic of the Lagos 
University Teaching Hospital, Lagos State, South West 
Nigeria. Approval was given by the Health Research 
and Ethics Committee of the institution. Consecutive 
CKD patients who agreed to participate in the study 
were recruited. The control group consisted of apparently 
healthy age-matched individuals from among staff and 
students. Demographic and clinical data were documented. 
The glomerular filtration rate (GFR) among patients was 
estimated using the using the 4-variable Modification of 
Diet in Renal Disease Study equation.[15]
Major depressive disorder (MDD) diagnoses are made 
according to a set of symptoms that are present for 2 weeks, 
involving both somatic and cognitive symptoms, including 
suicidal ideation.[1-3] A diagnosis of major depressive disorder 
should be made if during a period of at least 2 weeks, a 
patient experiences depressed mood most of the time or 
loss of interest or pleasure in usual activities and at least 
five of the following symptoms: loss of weight, change in 
sleep pattern, e.g., insomnia or hypersomnia, psychomotor 
retardation, fatigue or loss of energy most days, feelings 
of worthlessness or guilt, decreased ability to think or 
concentrate, suicidal ideation, and thoughts of death.[1] 
We used the Zung Self-rating Depression Scale (ZSDS), 
which is a widely validated 20-weighted item questionnaire 
including questions to identify the presence of affective, 
psychological and somatic symptoms associated with 
depression.[16] The cut-off for defining depression using 
the ZSDS is 50. A score of 60-69 is indicative of moderate 
depression	while	≥	70	 is	 severe	 depression.	The	ZSDS	
questionnaire was also translated into Yoruba and local 
English (pidgin English) for patients who could not speak 
English. The patients with end-stage renal disease (ESRD) 
on dialysis were compared with those with pre-dialysis 
CKD (stages 3 to 5 but not on dialysis) and CKD patients 
with controls. 
Data analysis
Data were analysed using Epi Info ® 2002. Continuous 
variables are presented as mean ± standard deviation 
(SD) and compared using students T test. Categorical 
variables are presented as proportions and compared using 
Yates corrected X2 test. Multivariate analysis was used to 
determine risk factors associated with depression. P value 
<0.05 is regarded as being statistically significant.
Results
A total of 118 CKD patients and 50 control subjects were 
interviewed. There were 73 (61.9%) male and 45 female 
(38.1%) patients; 26 (52%) male and 24 (48%) female 
control subjects. The mean age for the CKD patients 
and controls were similar (43.6 ± 15.1 for CKD patients 
and 40.3 ± 12.1 years, P = 0.17), age range was 16-87 
years. Table 1 shows the clinical data of the patients and 
controls. The duration of CKD ranged from 3 months to 36 
months. The etiology of CKD was hypertension in 50.8% 
of the patients, glomerulonephritis in 17.8%, diabetes in 
11%, unknown in 5.9% and other causes like obstructive 
nephropathy, human immunodeficiency virus associated 
nephropathy, sickle cell nephropathy and lupus nephritis 
accounted for 14.5%. 
Thirty-eight patients (30.6%) were in CKD stage III, 23 
(18.5%) CKD stage IV and 63 (50.8%) CKD stage V. The 
mean GFR for patients in stage III was 46.8 ± 8.58 ml/
minute/1.73m2, stage IV 19.8 ± 4.18 ml/minute/1.73m2 
and 8.13 ± 3.11 ml/minute/1.73m2. 
Prevalence of depression
CKD patients were much more likely to be depressed 
compared with controls; the prevalence of symptoms of 
depression among the CKD patients was 23.7%, while for 
the control group was 2% X2 = 10.14, P < 0.001. Further 
analysis showed that 10.5% of patients in CKD stage 3 had 
depression , 13% in CKD stage 4 and 33.3% in CKD stage 5 
X2 8.52, df 2 P= 0.014; 3.4% of CKD patients had moderate 
depression no case of severe depression was recorded in the 
study population. No difference was observed in the mean 
Table 1: Comparison of demographic characteristics and ZSDS parameters in CKD patients and controls
Clinical parameter CKD patients N = 118 Controls N = 50 P value
Mean age (years) ± SD 43.6 ± 15.1 40.3 ± 12.1 NS
Number of male/female subjects 73/45 26/24 NS
Mean Zung score ± SD 40.7 ± 11 34.0 ± 7.4 < 0.0001
Number of patients with depression 28 (23.7%) 1 (2%) < 0.01
ZSDS = Zung Self-rating Depression Scale
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Zung score among the male and female patients mean 
Zung score was 40.1 in females and 40.7 in male patients, 
P > 0.05.
When we compared the pre-dialysis CKD patients on 
conservative treatment with CKD patients on dialysis, 
the dialysis patients were more likely to be depressed with 
frequency of depressive symptoms of 34.5% in dialysis 
patients versus 13.3% in pre-dialysis patients X[2] = 6.17, 
P = 0.01 (OR 0.29, 95% CI 0.10-0.80). Table 2 shows 
comparison of clinico-demographic data in pre-dialysis and 
HD patients. Multivariate analysis showed that treatment 
modality was the only risk factor associated with depression. 
Duration of CKD, gender and age were not associated with 
CKD [Table 3].
Discussion
Depression is frequently seen in CKD patients both as a 
reaction to the diagnosis and treatment as well as the losses 
experienced in terms of health, life style, finances, and 
status.[1] In this study the frequency of depressive symptoms 
among patients with CKD was high. This is consistent 
with reports in the literature.[5,17-19] Aghanwa et al., using 
the Diagnostic and Statistical Manual of Mental Disorders 
revised third edition (DSM III), reported a prevalence of 
major depressive episode of 25% among patients undergoing 
haemodialysis in Ile-Ife compared with 0% among their 
controls.[17] Hedayati reported prevalence of major 
depressive episode of 21% among a cohort of male veterans 
with CKD using the DSM IV instrument.[18] Watnick et al., 
also found a high prevalence of depressive disorder in a small 
population of ESRD patients treated with both hemodialysis 
and peritoneal dialysis using the Beck Depression Inventory 
(BDI), the Patient Health Questionnaire 9 (PHQ-9), and 
a structured, clinical psychiatric interview.[19]
We noted a rising prevalence of depressive symptoms with 
increasing severity of CKD from 10.5% in CKD stage III 
to 33.3% in CKD stage V. This is similar to findings from 
the study by Hedayati et al., that reported an association of 
increased prevalence of depression and severe CKD using 
the BD) as a screening instrument and the National Institute 
of Mental Health Diagnostic Interview Schedule (DIS) for 
diagnosis of major depression. In their study patients with 
severe CKD, defined as GFR of <30 ml/minute were more 
likely to have depressive symptoms (54.5%) and major 
depression (21.6%) compared with those without severe 
CKD (32.8% and 13%, respectively).[5] 
In our study, patients with ESRD on dialysis were more likely 
to be depressed compared with the predialysis CKD patients. 
This differs from some reports in the literature which 
showed no difference in the prevalence of depression among 
pre-dialysis and ESRD patients.[18,20,21] Abdel-kaber et al., 
compared prevalence of depressive disorder among ESRD 
patients on haemodialysis and patients with CKD stages 4 
and 5 not on dialysis using Patient Health Questionnaire - 9 
(PHQ-9), they found no difference in prevalence of major 
depression among both groups.[20] The different instruments 
used for the assessment of depression in our study and other 
studies may account for these differences. Other possible 
reasons for the observed higher prevalence of depressive 
symptoms among our dialysis patients are: the huge financial 
burden of haemodialysis therapy in Nigeria and the fact 
that cost of treatment is borne entirely by patients and 
their relatives thus putting a strain on the family finances. 
In addition there are uncertainties about outcomes of 
treatment coupled with the fear of death and the severity 
of disease with its attendant numerous complications all of 
these could contribute to higher frequency of depression 
among these patients. There may also be marital conflicts, 
strained inter-personal relationships with family and medical 
personnel, and risk of job losses as a result of frequent 
absenteeism from work. 
Table 2: Comparison of demographic characteristics and ZSDS parameters in pre-dialysis and ESRD patients
Clinical parameter Pre-dialysis patients N =60 ESRD patients N = 58 P value
Mean age (years) ± SD 45.1 ± 15.1 42.0 ± 15.04 NS
Mean Zung score 37.4 ± 9.7 43.7 ± 0.2 0.0001
Number of patients with depression 8 (13.3%) 20 (34.5%) 0.007
Number of patients with moderate depression 1 (1.7%) 3 (5.2%) NS
ZSDS = Zung Self-rating Depression Scale; ESRD = End-stage renal disease
Table 3: Logistic regression analysis showing the risk factors associated with depression
Variable Coefficient Standard error F test P value
Age (years) 0.001 0.003 0.187 0.67
CKD duration (months) -0.008 0.005 2.358 0.13
Sex (male/female) -0.029 0.098 0.087 0.77
Treatment (HD/conservative) 0.181 0.092 3.893 0.05
CKD = Chronic kidney disease; HD = haemodialysis
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The effect of depression on survival is controversial, while 
a few studies involving small numbers have not shown 
any association between baseline depression scores and 
outcomes,[22,23] majority of studies showed that presence of 
depression impacts negatively on survival.[3,5,10] Depression 
has also been shown to impact negatively on the quality 
of life (QOL).[14] The mechanism whereby depression 
impacts on QOL and survival include non-compliance 
with medications and dialysis prescription, poor nutrition 
and possible increased inflammation from dysregulation of 
cytokine metabolism.[2,3]  
Despite the high prevalence of depression in ESRD, few 
patients diagnosed with depression are on treatment.[3] 
Reasons for this are lack of carefully planned randomised 
controlled trials evaluating the efficacy and safety of 
antidepressants in this population of patients. It is important 
to treat depression among CKD patients given its negative 
impact on survival and QOL. Cognitive behavioural therapy 
(CBT) has been recognised as an effective psychological 
treatment for mild to moderate depression. [14] A combination 
of antidepressants medications such as selective serotonin 
uptake inhibitors and psychotherapy may be the optimal 
form of therapy.[2,3] 
Our limitation is the use of self -reported measurement of 
depressive symptoms; we did not use the DSM IV instrument 
which is the gold standard for diagnosis of major depressive 
disorder (MDD). Further research using this instrument as 
well as carrying out a comparative study of prevalence of 
depression among patients with different chronic illnesses 
is desirable so as to assess the impact of the chronic medical 
illness on depression as well as on outcomes.
Conclusions
In conclusion, depressive symptoms are common among 
patients with CKD and treatment modality was the major 
predictor of depression among our patients. Patients with 
CKD should be screened routinely for depression.
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